Skip to main content

Walleye Capital LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1758720 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$0
-$6,923,937 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
10 quarters on record

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Jun 30, 2026
CallValue
$214,780
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $214,780 400
2026-03-31 $6,923,937 13,227
2026-03-31 $680,511 1,300
2025-12-31 $40,181 69
2025-12-31 $349,404 600
2025-12-31 $407,638 700
2025-09-30 $1,238,382 2,700
2025-09-30 $412,794 900
2025-06-30 $87,160 288
2025-06-30 $121,056 400
2025-06-30 $121,056 400
2025-03-31 $99,369 300
2025-03-31 $231,861 700
2024-12-31 $339,427 1,100
2024-06-30 $112,064 400
2024-06-30 $252,144 900
2024-06-30 $16,249 58
2024-03-31 $291,874 1,093
2024-03-31 $53,408 200
2024-03-31 $133,520 500
2023-03-31 $242,260 1,000
2023-03-31 $96,904 400